
Sign up to save your podcasts
Or


A Note from James:
One of my favorite conversations on this show was with Peter Thiel. Yes—PayPal, Facebook, Palantir, and a dozen other hits. I first ran this episode years ago, and the advice still holds up. The same stories, the same frameworks—and the same challenge to think from first principles. Here’s Peter Thiel, one of the most influential entrepreneurs of our time.
Episode Description:
In this redux, James pressure-tests the core ideas from Peter Thiel’s Zero to One—why competition is for losers, how real monopolies are built, and why starting “narrow” is often the only path to something huge. They cover Facebook’s early moat (real identity), PayPal’s network-effect wedge on eBay, and the “10x or nothing” bar for proprietary technology. Peter shares a contrarian read on bubbles, why biotech’s slump may be opportunity, and how to hire, divide roles, and keep teams from fighting. The through-line: seek secrets, combine disciplines, and make something so different that it becomes its own category.
What You’ll Learn:
Timestamped Chapters:
Additional Resources:
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
By James Altucher4.6
24762,476 ratings
A Note from James:
One of my favorite conversations on this show was with Peter Thiel. Yes—PayPal, Facebook, Palantir, and a dozen other hits. I first ran this episode years ago, and the advice still holds up. The same stories, the same frameworks—and the same challenge to think from first principles. Here’s Peter Thiel, one of the most influential entrepreneurs of our time.
Episode Description:
In this redux, James pressure-tests the core ideas from Peter Thiel’s Zero to One—why competition is for losers, how real monopolies are built, and why starting “narrow” is often the only path to something huge. They cover Facebook’s early moat (real identity), PayPal’s network-effect wedge on eBay, and the “10x or nothing” bar for proprietary technology. Peter shares a contrarian read on bubbles, why biotech’s slump may be opportunity, and how to hire, divide roles, and keep teams from fighting. The through-line: seek secrets, combine disciplines, and make something so different that it becomes its own category.
What You’ll Learn:
Timestamped Chapters:
Additional Resources:
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

16,125 Listeners

3,369 Listeners

2,691 Listeners

2,172 Listeners

4,690 Listeners

3,988 Listeners

4,913 Listeners

2,120 Listeners

2,647 Listeners

166 Listeners

554 Listeners

992 Listeners

88 Listeners

662 Listeners

135 Listeners